These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 4602392

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hypertension: selection of treatment in relation to the mechanisms raising blood pressure.
    Conway J.
    Brux Med; 1973 Nov; Spec No(0):87-98. PubMed ID: 4371910
    [No Abstract] [Full Text] [Related]

  • 3. [Role of the sympathetic-adrenal system in the pathogenesis of essential arterial hypertension].
    Manasia M, Spânu C.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984 Nov; 36(6):481-8. PubMed ID: 6152066
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Activity of sympatho-adrenal system in essential hypertension patients].
    Lohmann FW, Dissmann T, Gotzen R, Molzahn M, Schröder G.
    Verh Dtsch Ges Inn Med; 1973 Nov; 79():809-12. PubMed ID: 4790003
    [No Abstract] [Full Text] [Related]

  • 9. [On the pathogenesis of sympatho-adrenal dysfunction in cerebral and cardiac manifestations of hypertensive disease and atherosclerosis].
    Savenko SN, Vladkovskiĭ IK, Maĭdanik FE.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968 Nov; 68(3):391-6. PubMed ID: 5658305
    [No Abstract] [Full Text] [Related]

  • 10. [Is essential hypertension still a disease entity? Definition of hyporeninemic hypertension].
    Distler A.
    Internist (Berl); 1974 Mar; 15(3):146-54. PubMed ID: 4600300
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Long-term drug therapy of arterial hypertension including patient compliance].
    Linss G, Kiesewetter R.
    Z Arztl Fortbild (Jena); 1984 Mar; 78(24):1047-53. PubMed ID: 6442069
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High blood pressure management: potential benefits of I1 agents.
    Esler M.
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The control of renin secretion: experimental data and clinical implications].
    Zanchetti A, Leonetti G, Morganti A, Terzoli L, Stella A.
    Atti Soc Ital Cardiol; 1978 Aug; 37():46-59. PubMed ID: 356832
    [No Abstract] [Full Text] [Related]

  • 18. [Therapeutic progress in the area of arterial hypertension].
    Verniory A, Demanet JC.
    Brux Med; 1974 Oct; 54(10):551-8. PubMed ID: 4373143
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The renin-angiotensin system and hypertension.
    Williams GH.
    Clin Exp Pharmacol Physiol Suppl; 1982 Oct; 7():31-40. PubMed ID: 6754184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.